Our results showed that HAVCR1 was overexpressed while the promoter methylation of HAVCR1 was decreased in Liver hepatocellular carcinoma and Pancreatic adenocarcinoma. The gene discussed is HAVCR1; the disease is pancreatic adenocarcinoma.